Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
The COVID-19 pandemic has provided a strong reminder for the scientific community about the importance of public understanding and...
In a 1735 letter to the citizens of Philadelphia about the need to tighten the city’s fire safety measures,...
Guest post by Ned Sharpless, MD, FAACR As I announced a short time ago, I have decided to step...
Excitement and emotion ran high Sunday morning as Margaret Foti, PhD, MD (hc), chief executive officer of the American...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
In 2015, NFL running back Brandon Bolden was having an incredible season with the New England Patriots. That year,...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...